Ifp Advisors, Inc Seelos Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.51 - $0.93 $606 - $1,106	1,190 New	1,190 $5,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $606 - $1,106	-1,190 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.35 - $4.99 $1,606 - $5,938	1,190 New	1,190 $6,000
Q4 2020 Jan 25, 2021	BUY	$0.74 - $2.01 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$0.6 - $1.25 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$0.42 - $1.51 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	SELL	$0.47 - $1.56 $7 - $24	-16 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$0.92 - $2.15 $14 - $34	16 New	16 $0

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.